Stability of an extemporaneous oral liquid aprepitant formulation

被引:0
|
作者
L. Lee Dupuis
Karen Lingertat-Walsh
Scott E. Walker
机构
[1] The Hospital for Sick Children,Division of Hematology/Oncology, Department of Pharmacy, Research Institute
[2] The Hospital for Sick Children,Department of Pharmacy
[3] University of Toronto,Leslie Dan Faculty of Pharmacy
[4] Sunnybrook Health Sciences Center,Department of Pharmacy
来源
Supportive Care in Cancer | 2009年 / 17卷
关键词
Aprepitant; Suspension; Compounding;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:701 / 706
页数:5
相关论文
共 50 条
  • [41] EXTEMPORANEOUS ORAL POETRY IN CENTRAL ITALY
    KEZICH, G
    FOLKLORE, 1982, 93 (02) : 193 - 205
  • [42] Comparative Bioavailability and Pharmacokinetics Between the Solid Form of Metformin vs a Novel Liquid Extemporaneous Formulation in Children
    Alemon-Medina, Radames
    Altamirano-Bustamante, Nelly
    Lugo-Goytia, Gustavo
    Garcia-Alvarez, Raquel
    Rivera-Espinosa, Liliana
    Torres-Espindola, Luz Maria
    Chavez-Pacheco, Juan Luis
    Juarez-Olguin, Hugo
    Gomez-Garduno, Josefina
    Flores-Perez, Carmen
    Fernandez-Perez, Paola Gabriela
    DOSE-RESPONSE, 2021, 19 (03):
  • [43] Design and stability of pediatric oral formulation of imatinib
    Hinterlang, Melanie
    Gendron, Amandine
    Fleury, Thomas
    Rieutord, Andre
    Vrana, Anastasia
    Schlatter, Joel
    Annereau, Maxime
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (02) : 337 - 342
  • [44] Stability of extemporaneous sulfadiazine oral suspensions from commercially available tablets for treatment of congenital toxoplasmosis
    Soares Rodrigues Costa, Brunna
    Pontes do Nascimento, Leandro
    de Paiva Amorim, Marcelo Vitor
    Barreto Gomes, Ana Paula
    Mafra Verissimo, Lourena
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2020, 25 (03) : 364 - 372
  • [45] Stability of a flavored formulation of acetylcysteine for oral administration
    Siden, Rivka
    Johnson, Cary E.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2008, 65 (06) : 558 - 561
  • [46] Improving policies and practices for the extemporaneous compounding of oral liquid dosage forms in Saudi Arabian hospitals
    Joosub, Imraan
    Emara, Zohair
    Gray, Andy
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2021, 28 (05) : 280 - 283
  • [47] Isoniazid - new formulation (oral liquid) - EMLc
    SELECTION AND USE OF ESSENTIAL MEDICINES: REPORT OF THE WHO EXPERT COMMITTEE ON SELECTION AND USE OF ESSENTIAL MEDICINES, 2019 (INCLUDING THE 21ST WHO MODEL LIST OF ESSENTIAL MEDICINES AND THE 7TH WHO MODEL LIST OF ESSENTIAL MEDICINES FOR CHILDREN), 2019, 1021 : 109 - 113
  • [48] Stability of Olmesartan Medoxomil Extemporaneous Suspensions
    Bhattarai, Prapanna
    McPherson, Timothy
    Nieto, Marcelo
    Kolling, William M.
    JOURNAL OF PHARMACY TECHNOLOGY, 2022, 38 (01) : 3 - 9
  • [49] Stability of mycophenolate mofetil as an extemporaneous suspension
    Venkataramanan, R
    McCombs, JR
    Zuckerman, S
    McGhee, B
    Pisupati, J
    Dice, JE
    ANNALS OF PHARMACOTHERAPY, 1998, 32 (7-8) : 755 - 757
  • [50] Stability of pyridoxal phosphate extemporaneous liquids
    Mohamed-Ahmed, Abeer
    Chen, Ting
    Clayton, Peter
    Fotitt, Emma
    Davies, Elin
    Tuleu, Catherine
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2016, 511 (02) : 1150 - 1150